Belongs to

• Solid Tumor Oncology Division

Types of Work

["2022"]

[[["Journal Articles",1110],["Meeting Abstracts",903],["Reviews",55],["Book Sections",46],["Editorials",37],["Guidelines",22],["Correspondences",9],["Miscellaneous",3],["Research Letters",2],["Book Wholes",1]]]

[2188]

Popular keywords

• adult
• aged
• article
• clinical trial
• controlled study
• female
• human
• humans
• major clinical study
• middle aged

Recent Works

1. GOG-3097/ENGOT-ov81/GTG-UK/RAMP 301: A phase 3, randomized trial evaluating avutometinib plus defactinib compared with investigator's choice of treatment in patients with recurrent low grade serous ovarian cancer

   Journal Article

   Grisham, R.; Monk, B. J.; Van Nieuwenhuysen, E.; Moore, K. N.; Fabbro, M.; O'Malley, D. M.; Oaknin, A.; Thaker, P.; Oza, A. M.; Colombo, N.; more...
   International Journal of Gynecological Cancer (2025)

   Fulltext@MSK | Save
2. Health disparities among women who received treatment for 1L advanced and recurrent endometrial cancer in the United States

   Meeting Abstract

   McClain, K. M.; Prabhu, V. S.; Marupuru, S.; Meng, K.; Tran, V.; Woodhouse, K.; Meng, R.; Green, A. K.; Makker, V.
   Cancer Epidemiology Biomarkers and Prevention (2025)

   Fulltext@MSK | Save
3. PYNNACLE phase II clinical trial protocol: Rezatapopt (PC14586) monotherapy in advanced or metastatic solid tumors with a TP53 Y220C mutation

   Journal Article

   Schram, A. M.; Fellous, M.; LeDuke, K.; Schmid, A.; Dumbrava, E. E.
   Future Oncology (2025)

   Fulltext@MSK | Save